| Literature DB >> 34667222 |
Chih-Chia Chen1,2, Tsung Yu3, Hsin-Hsu Chou4,5, Yuan-Yow Chiou6,7, Pao-Lin Kuo8.
Abstract
The pathogenesis of nephrotic syndrome is unclear. We conducted a nationwide population-based cohort study to examine the associations between preterm births and subsequent development of NS. NS was defined as ≥ 3 records with ICD-9-CM codes for NS in hospital admission or outpatient clinic visits. To avoid secondary nephrotic syndrome or nephritis with nephrotic range proteinuria, especially IgA nephropathy, we excluded patients with associated codes. A total of 78,651 preterm infants (gestational age < 37 weeks) and 786,510 matched term infants born between 2004 and 2009 were enrolled and followed until 2016. In the unadjusted models, preterm births, maternal diabetes, and pregnancy induced hypertension were associated with subsequent NS. After adjustment, preterm births remained significantly associated with NS (p = 0.001). The risk of NS increased as the gestational age decreased (p for trend < 0.001). Among the NS population, preterm births were not associated with more complications (Hypertension: p = 0.19; Serious infections: p = 0.63, ESRD: p = 0.75) or a requirement for secondary immunosuppressants (p = 0.61). In conclusion, preterm births were associated with subsequent NS, where the risk increased as the gestational age decreased. Our study provides valuable information for future pathogenesis studies.Entities:
Mesh:
Year: 2021 PMID: 34667222 PMCID: PMC8526683 DOI: 10.1038/s41598-021-00164-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic data for the preterm and matched term infants.
| Preterm (n = 78,651) | Term (n = 786,510) | ||
|---|---|---|---|
| Male, n (%) | 44,960 (57.2) | 449,600 (57.2) | 1.000 |
| Birth year, n (%) | 1.000a | ||
| 2004 | 14,232 (18.1) | 142,320 (18.1) | |
| 2005 | 13,066 (16.6) | 130,660 (16.6) | |
| 2006 | 12,805 (16.3) | 128,050 (16.3) | |
| 2007 | 12,896 (16.4) | 128,960 (16.4) | |
| 2008 | 13,195 (16.8) | 131,950 (16.8) | |
| 2009 | 12,457 (15.8) | 124,570 (15.8) | |
| Gestational age groups, n (%) | |||
| ≤ 28 wks | 2158 (2.7) | 0 (0.0) | |
| 29–31 wks | 3804 (4.8) | 0 (0.0) | |
| 32–36 wks | 72,689 (92.4) | 0 (0.0) | |
| ≥ 37 wks | 0 (0.0) | 786,510 (100.0) | |
| SGA, n (%) | 5202 (6.6) | 76,769 (9.8) | < 0.001*** |
| Urbanization level, n (%) | < 0.001***b | ||
| 1 or 2 (lowest) | 7374 (9.4) | 63,834 (8.1) | |
| 3 or 4 | 13,574 (17.3) | 130,050 (16.5) | |
| 5 | 18,705 (23.8) | 182,671 (23.2) | |
| 6 | 23,305 (29.6) | 241,865 (30.8) | |
| 7 | 15,693 (20.0) | 168,090 (21.4) | |
| Family income, quartile, n (%) | < 0.001***c | ||
| Dependent or first | 22,698 (28.9) | 185,418 (23.6) | |
| Second | 20,127 (25.6) | 202,274 (25.7) | |
| Third | 18,422 (23.4) | 198,856 (25.3) | |
| Fourth | 17,404 (22.1) | 199,962 (25.4) | |
| Maternal age, year, mean (SD) | 29.8 (5.2) | 29.4 (4.8) | < 0.001*** |
| Paternal age, year, mean (SD) | 33.0 (5.7) | 32.6 (5.3) | < 0.001*** |
| Maternal complication, n (%) | |||
| RA | 139 (0.2) | 994 (0.1) | < 0.001*** |
| SLE | 427 (0.5) | 1852 (0.2) | < 0.001*** |
| DM | 1819 (2.3) | 7246 (0.9) | < 0.001*** |
| GDM | 8855 (11.3) | 81,927 (10.4) | < 0.001*** |
| Chronic HTN | 2600 (3.3) | 6134 (0.8) | < 0.001*** |
| PIH | 5266 (6.7) | 14,631 (1.9) | < 0.001*** |
| Asthma | 401 (0.5) | 2635 (0.3) | < 0.001*** |
The family income was assessed at birth and was classified into four quartiles based on each birth year. PIH was defined as hypertension that complicated pregnancy after 20 weeks of gestation.
DM diabetes mellitus, GDM gestational diabetes mellitus, HTN hypertension, PIH pregnancy-induced hypertension, RA rheumatoid arthritis, SGA small for gestational age, SLE systemic lupus erythematosus.
aThe p value implied the differences of the birth year distributions between preterm and term infants.
bThe p value implied the differences of urbanization distributions between preterm and term infants.
cThe p value implied the differences of family income distributions between preterm and term infants.
***p < 0.001.
Comparison of the incidence of subsequent nephrotic syndrome in the different gestational age groups.
| NS numbers | Person-years | Incidence (per 100,000 person-years) | Crude HR | Adjusted HR# | |||
|---|---|---|---|---|---|---|---|
| Preterm | |||||||
| Yes | 50 | 707,104 | 7.1 | 1.76 (1.30, 2.38)*** | < 0.001*** | 1.70 (1.24, 2.34)** | 0.001** |
| No | 285 | 7,097,877 | 4.0 | Ref | Ref | ||
| Gestational age | |||||||
| ≤ 28 wks | 5 | 18,333 | 27.3 | 6.41 (2.88, 16.89)*** | < 0.001*** | 6.16 (2.28, 16.65)*** | < 0.001*** |
| 29–31 wks | 6 | 33,778 | 17.8 | 4.40 (1.96, 9.87)*** | < 0.001*** | 3.85 (1.62, 9.13)** | 0.002** |
| 32–36 wks | 39 | 654,993 | 6.0 | 1.48 (1.06, 2.07)* | 0.021* | 1.48 (1.04, 2.10)* | 0.031* |
| ≥ 37 wks | 285 | 7,097,877 | 4.0 | Ref | Ref | ||
| Gestational age | 0.90 (0.85 ~ 0.96)** | 0.001** | 0.90 (0.85 ~ 0.97)** | 0.003** | |||
| Maternal diabetes | |||||||
| Yes | 8 | 81,044 | 9.9 | 2.33 (1.15, 4.69)* | 0.018* | 1.69 (0.76 ~ 3.77) | 0.20 |
| No | 327 | 7,723,937 | 4.2 | Ref | Ref | ||
| Maternal PIH | |||||||
| Yes | 13 | 176,625 | 7.4 | 1.75 (1.01, 3.05)* | 0.048* | 1.53 (0.87 ~ 2.73) | 0.14 |
| No | 322 | 7,628,356 | 4.2 | Ref | Ref | ||
PIH was defined as hypertension that complicated pregnancy after 20 weeks of gestation.
#Adjusted for SGA, urbanization, family income, paternal age, maternal age and maternal complications. ## p for trend was to test the effect of varying gestational age on the incidence of nephrotic syndrome.
*p < 0.05, **p < 0.01, ***p < 0.001.
Figure 1Probability of nephrotic syndrome free survival. The Kaplan–Meier nephrotic syndrome-free survival curves were according to (A) preterm and term infants and (B) the different gestational age groups. Due to data confidentiality, the number of individuals followed up for each time interval cannot be shown.
Figure 2Relationships between gestational age and the age when nephrotic syndrome diagnosed. The Pearson correlation analyses showed that the correlation coefficient between gestational age and the age when nephrotic syndrome diagnosed was low.
Odds ratio for nephrotic syndrome complications and use of immunosuppressants other than steroids.
| Preterm | Incidence (per 100 infants) | Term (ref) | Incidence (per 100 infants) | OR | ||
|---|---|---|---|---|---|---|
| Hypertension | 3 | 6 | 7 | 2.5 | 2.54 (0.63, 10.15) | 0.19 |
| Serious infections | 7 | 14 | 33 | 11.6 | 1.24 (0.48–2.84) | 0.63 |
| Secondary immunosuppressants usage | 14 | 28 | 90 | 31.6 | 0.84 (0.43, 1.64) | 0.61 |
ESRD End stage of renal disease.
Comparison of gestational ages between nephrotic syndrome patients with and without secondary immunosuppressants usage or complications.
| Hypertension (n = 10) | No hypertension (n = 325) | ||
|---|---|---|---|
| Gestational age, median (IQR) | 39 (36–39) | 38 (37–39) | 0.73 |
ESRD End stage of renal disease.